Founded in 1993, The Surgical Company BV (now TSC Life) initially focused on the Benelux markets specializing in surgery, anesthesia, and intensive care. TSC then merged with Granulab BV and Granulab Sarl in 2000, to diversify its portfolio to compete in patient temperature management (PTM). TSC Life created The 37Company (NL) in 2007 to expand capabilities in R&D, manufacturing, and global exports in the field of PTM. In subsequent years, they commercialized Fluido® AirGuard, Fluido® Compact, and Mistral-Air®, which THS will represent exclusively in Canada.
To date, TSC Life has over 30 years of experience and operates directly in 5 markets, has 4 regional offices, and distributes in over 78 countries globally. TSC Life owns cutting-edge production facilities that are strategically located in Almelo, Netherlands, and Tours, France. These sites are critical hubs of innovation, where they design, develop, and manufacture products that drive a focal mission of transforming patient care. Their core mission is to drive innovation by creating evidence-based solutions that empower healthcare professionals to improve patient outcomes. With a bold vision of touching the lives of 25 million patients annually, they aim to disrupt the healthcare market through agility, integrity, and reliability. TSC Life’s commitment to continuous improvement ensures that they not only meet but exceed the expectations of their respective partners, patients, and stakeholders, fostering a healthier, more sustainable future for all.
